Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating promising results in the control of type 2 diabetes. This synthetic peptide resembles the actions of naturally present GLP-1, a hormone https://ok-social.com/story6373531/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes